| Literature DB >> 34668461 |
Qisheng Su1, Zheng Yang1, Xiaobin Guo2, Wuning Mo1, Xiaohong Li1.
Abstract
The function of tubulin polymerization promoting protein family member 3 (TPPP3) in tumor cells is complicated, and the role of TPPP3 in nasopharyngeal carcinoma (NPC) remains unclear. This study aims to explore the expression of TPPP3 in NPC and its effect on NPC cells. The expression of TPPP3 in NPC tissues and other cancers were analyzed by using the Oncomine and Gene Expression Omnibus (GEO) databases. The mRNA and protein of TPPP3 were detected in NPC tissues by quantitative real-time PCR and immunohistochemistry. Furthermore, TPPP3 was overexpressed in 5-8 F and HONE1 cell lines by lentivirus transfection, and functional analysis of TPPP3 in NPC was evaluated through in vitro experiments. The expression of TPPP3 was significantly down-regulated in NPC tissues and cells. Overexpression of TPPP3 significantly inhibited proliferation of 5-8 F and HONE1 cells in vitro. In addition, overexpression of TPPP3 significantly attenuated the invasion ability of 5-8 F, HONE1 cells in vitro, but have no significant effect on migration ability. Furthermore, TPPP3 overexpression diminished the expression of MMP-2 and MMP-9 mRNA. By analyzing dataset GSE12452, it was interesting that TPPP3 high expression group mainly functioned in B cell receptor signaling pathway, cell cycle and DNA replication. In conclusion, our results suggest that TPPP3 may be considered as an antioncogene, which plays an important role in the occurrence and progression of NPC.Abbreviations: TPPP3: tubulin polymerization promoting protein family member 3; NPC: nasopharyngeal carcinoma; GEO: Gene Expression Omnibus; qRT-PCR: quantitative real-time PCR; GFP: green fluorescence protein; MOI, transfected multiplicity of infection; CCK-8: cell counting kit-8; OD: optical density; GSEA: gene set enrichment analysis; GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; MMP-2: matrix metalloproteinase-2; MMP-9: matrix metalloproteinase-9.Entities:
Keywords: Nasopharyngeal carcinoma; TPPP3; invasion; migration; proliferation
Mesh:
Substances:
Year: 2021 PMID: 34668461 PMCID: PMC8806723 DOI: 10.1080/21655979.2021.1984006
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 3.269
Sequences of primers
| Gene | Forward primer (5→3ʹ) | Reverse primer (5ʹ→3ʹ) |
|---|---|---|
| TPPP3 | GGCAAGAGATGAATGGCAAGA | CATAGTTGATGACCCGAGCAGA |
| GAPDH | TGACTTCAACAGCGACACCCA | CACCCTGTTGCTGTAGCCAAA |
| MMP-2 | TTGATGGCATCGCTCAGATC | TTGTCACGTGGCGTCACAGT |
| MMP-9 | GACGCAGACATCGTCATCCA | CACAACTCGTCATCGTCGAAA |
| β-actin | TTGCCGACAGGATGCAGAAGGA | AGGTGGACAGCGAGGCCAGGAT |
Figure 1.TPPP3 expression in human cancers
Figure 2.Expression of TPPP3 is reduced in NPC tissues and cell lines
The expression of TPPP3 in NPC and chronic nasopharyngitis tissues
| Group | N | Positive(+) | Negative (-) | Positive rate (%) | |
|---|---|---|---|---|---|
| NPC | 72 | 7 | 65 | 9.72 | <0.001 |
| chronic nasopharyngitis | 51 | 47 | 4 | 92.16 |
The correlation between TPPP3 expression and clinicopathological parameters in NPC
| Group | N | Negative (-) | Positive(+) | Positive rate (%) | |
|---|---|---|---|---|---|
| Gender | |||||
| male | 50 | 45 | 5 | 10.00 | >0.05 |
| female | 22 | 20 | 2 | 9.09 | |
| Age | |||||
| ≤45 | 30 | 27 | 3 | 10.00 | >0.05 |
| >45 | 42 | 38 | 4 | 9.52 | |
| Differentiation or not | |||||
| differentiated | 7 | 6 | 1 | 14.29 | >0.05 |
| undifferentiated | 65 | 59 | 6 | 9.23 | |
| T classification | |||||
| T1&T2 | 17 | 15 | 2 | 11.76 | >0.05 |
| T3&T4 | 55 | 50 | 5 | 9.09 | |
| N classification | |||||
| N0&N1 | 21 | 19 | 2 | 9.52 | >0.05 |
| N2&N3 | 51 | 46 | 5 | 9.80 | |
| M classification | |||||
| M0 | 63 | 57 | 6 | 9.52 | >0.05 |
| M1 | 9 | 8 | 1 | 11.11 | |
| Tumor stage | |||||
| I&II | 8 | 7 | 1 | 12.50 | >0.05 |
| III&IV | 64 | 58 | 6 | 9.38 |
Figure 3.Construction of TPPP3 overexpression stable cell lines
Figure 4.TPPP3 overexpression inhibited NPC cells proliferation
Figure 5.TPPP3 overexpression had no significant effect on the migration ability in NPC
Figure 6.TPPP3 overexpression attenuated NPC cells invasion
Significantly enriched KEGG pathways
| NAME | ES | NES | NOM p-val | FDR q-val |
|---|---|---|---|---|
| ANTIGEN PROCESSING AND PRESENTATION | 0.584 | 1.730 | 0.010 | 0.207 |
| COMPLEMENT AND COAGULATION CASCADES | 0.624 | 1.718 | 0.004 | 0.117 |
| CALCIUM SIGNALING PATHWAY | 0.438 | 1.713 | 0.000 | 0.085 |
| AUTOIMMUNE THYROID DISEASE | 0.680 | 1.682 | 0.012 | 0.097 |
| B CELL RECEPTOR SIGNALING PATHWAY | 0.650 | 1.669 | 0.014 | 0.094 |
| LEISHMANIA INFECTION | 0.690 | 1.648 | 0.006 | 0.102 |
| VIRAL MYOCARDITIS | 0.604 | 1.645 | 0.014 | 0.091 |
| HEMATOPOIETIC CELL LINEAGE | 0.674 | 1.613 | 0.015 | 0.112 |
| GRAFT VERSUS HOST DISEASE | 0.729 | 1.580 | 0.032 | 0.138 |
| CELL ADHESION MOLECULES CAMS | 0.582 | 1.578 | 0.016 | 0.127 |
| LEUKOCYTE TRANSENDOTHELIAL MIGRATION | 0.533 | 1.575 | 0.019 | 0.118 |
| INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION | 0.739 | 1.571 | 0.013 | 0.112 |
| ASTHMA | 0.730 | 1.569 | 0.008 | 0.107 |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 0.656 | 1.538 | 0.021 | 0.130 |
| TYPE I DIABETES MELLITUS | 0.663 | 1.511 | 0.036 | 0.146 |
| ALLOGRAFT REJECTION | 0.715 | 1.505 | 0.048 | 0.143 |
| PRIMARY BILE ACID BIOSYNTHESIS | 0.603 | 1.4914 | 0.044 | 0.150 |
| CHEMOKINE SIGNALING PATHWAY | 0.488 | 1.459 | 0.029 | 0.173 |
| DILATED CARDIOMYOPATHY | 0.368 | 1.414 | 0.040 | 0.190 |
| AMINO SUGAR AND NUCLEOTIDE SUGAR METABOLISM | −0.590 | −1.530 | 0.030 | 0.196 |
| PENTOSE PHOSPHATE PATHWAY | −0.623 | −1.544 | 0.042 | 0.185 |
| GLYOXYLATE AND DICARBOXYLATE METABOLISM | −0.597 | −1.550 | 0.038 | 0.189 |
| DNA REPLICATION | −0.733 | −1.559 | 0.045 | 0.190 |
| GALACTOSE METABOLISM | −0.555 | −1.562 | 0.029 | 0.202 |
| SELENOAMINO ACID METABOLISM | −0.551 | −1.567 | 0.037 | 0.212 |
| SPLICEOSOME | −0.588 | −1.590 | 0.043 | 0.191 |
| CELL CYCLE | −0.627 | −1.597 | 0.021 | 0.199 |
| HOMOLOGOUS RECOMBINATION | −0.626 | −1.602 | 0.0483 | 0.218 |
| MISMATCH REPAIR | −0.755 | −1.609 | 0.027 | 0.234 |
| GLYCOSYLPHOSPHATIDYLINOSITOL GPI ANCHOR BIOSYNTHESIS | −0.636 | −1.670 | 0.008 | 0.248 |